NeuroScientific Biopharmaceuticals has landed key US backing for its Phase 2 stem cell Crohn’s trial, green-lighting a planned year-end start subject to final preparations.

https://www.brisbanetimes.com.au/business/companies/neuroscientific-biopharmaceuticals-clears-key-us-crohn-s-trial-hurdle-20261013-p6156v.html?ref=rss&utm_medium=rss&utm_source=rss_business

#brisbanetimes